Panacea Life Sciences Holdings Inc · OTC:PLSH

Panacea Life Sciences — Exactus — Investor Presentation (May 2019)

17 slides from Panacea Life Sciences's investor presentation, May 2, 2019

  1. Slide 1: Hemp CBD From Seed

    EXAC=US HEMP CBD FROM SEED — GENETIC SCIENCE STARTS WITH THE SEED OTCQB: EXD! May 2019

  2. Slide 2: Cautionary Note Regarding Forward-Looking Statements

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets for future development and/or otherwise are not statements of historical fac

  3. Slide 3: Defining Our Hemp Playing Field - Mission Statement

    Defining Our “Hemp” Playing Field — Exactus’s Mission Statement MISSION STATEMENT * Our mission is to become the most trusted name in the CBD business. + We are intently focused on developing and providing consumers with healthy hemp derived products. We are committed to a hem future in which produc

  4. Slide 4: Corporate Overview

    CORPORATE OVERVIEW Operating Goals * Private Label and Exactus Branded Hemp-Based CBD Products * Majority Interest in 200 Acre Industrial Hemp Farm * Assisting Medical and Health-Care Professionals with Hemp Derived Education and Products + Pharmacy Sales of Hemp Derived Consumables Planned * Sponso

  5. Slide 5: USA Hemp/CBD Market Opportunity

    USA HEMP/CBD MARKET OPPORTUNITY $367M ie 2017 ~ Sales of $367M and 2018 — Hemp derived CBD The US market for Hemp represents a expected to be >$500M in 2018* outpacing other cannabis derived massive opportunity to early movers cep and innovators al ~60% The Brightfield Group estimates the total CBD

  6. Slide 6: The Exactus Advantage

    THE EXACTUS ADVANTAGE Master Development and Supply Agreement —_Exactus Products * Partnered with Ceed2Med, our largest + Full spectrum whole plant extract and isolate shareholder, for dedicated supply of biomass, used in all our products genetics, isolate/distillate for branded and white + Increasi

  7. Slide 7: Exclusive Manufacturing and Development Partnership

    EXCLUSIVE MANUFACTURING AND DEVELOPMENT PARTNERSHIP All Stages of Production to the highest cGMP, food grade standards + Ability to tack and trace every unit back to the farm + Seed to sale chain of custody + Product lability insurance ell; Multi year Master Supply and Development ‘Agreement Se Prem

  8. Slide 8: Exactus Branded Products

    Exactus Branded Products * Full spectrum whole plant extract (entourage effect from full spectrum cannabidiol oil + pure 99% crystalline cannabidiol) * Trusted quality assurance through third party lab testing & cGMP. cl for all of our CBD products ke full Hemp” = ie 4 etn Extract ot ae & % na sano

  9. Slide 9: Production & Manufacturing

    Production & Manufacturing + Planting activities have commenced, with the starting mix and seed planting in the Company's greenhouses je + Delivery of raw materials (isolate and distillate) began in = April 2019 thus launching the start of product development at two locations Farming techniques + Un

  10. Slide 10: Seed to Sale Tracking

    SEED TO SALE TRACKING Manufacturing Extraction Consumer Transportation a Cultivation @) Fibers. g " @ Harvest EXAC#US

  11. Slide 11: Investment Highlights

    INVESTMENT HIGHLIGHTS = \\\)\ Leading the development of and exceeding current oo industry standards Highest quality products on the market + Patent pending formulation technology + Patent focused cw) [Za Healthcare and professional focused, “high-end” sales call strategy + Premium pricing and margi

  12. Slide 12: Management

    MANAGEMENT JONATHAN GILBERT EXECUTIVE CHAIRMAN + Founder and CEO of Scythian Biosciences, Inc. from 2014 through May of 2018. + Seythian Biosciences, Inc. is a publicly-traded research and development company focusing ‘on the prevention and treatment of concussions and traumatic brain injury with it

  13. Slide 13: Advisory Board

    ADVISORY BOARD EMILIANO ALO! PRESIDENT & SENIOR ADVISOR + Co-founder of Ceed2Med, LLC + Vice President, Strategic Development and Director, Strategic Development, GenCanna Global ‘+ Agro-industrial Supply and Market Development Professional + Co-sponsored research programs for Stevia and Aloe Vera i

  14. Slide 14: Board of Directors

    BOARD OF DIRECTORS JOHN PRICE Independent Director + John Price currently serves as Chief Financial Officer, Treasurer and Secretary of SCWorx Corp., a publicly-traded provider of data normalization, application interoperability and big data analytics within the healthcare provider market. + Previou

  15. Slide 15: 2019 Milestones

    2019 MILESTONES Majority ownership in 200 acre industrial hemp farm & $1 million purchase order. Ql, 2019 } Ceed2Med qi, 2019 Q2, 2019 a Complete the Development and build out of the Supply Agreement commercial team. executed. E-commerce Recapitalization and platform launch. Board of Director Begin

  16. Slide 16: Summary

    SUMMARY OTCQB listed, planned NASDAQ uplisting with future public offering Executed Master Product Development and Supply ‘Agreement Full control over all aspects of the product lifecycle + Seed to final product tracking and accountability + Highest standards throughout the product lifecycle Majorit

  17. Slide 17: Contact

    EXAC#-US From The Seed To The Final Product, Only The Highest Standards. Leading The Way. Raising The Bar. For further information contact: Philip Young, Chief Executive Officer Email [email protected] Andrew Johnson, Chief Strategy Officer Email [email protected]

Exactus — Investor Presentation (May 2019) on 6ix